These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31331331)

  • 1. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells.
    Senbanjo LT; AlJohani H; Majumdar S; Chellaiah MA
    Cell Commun Signal; 2019 Jul; 17(1):80. PubMed ID: 31331331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
    Gupta A; Cao W; Chellaiah MA
    Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells.
    Senbanjo LT; AlJohani H; AlQranei M; Majumdar S; Ma T; Chellaiah MA
    Cancer Drug Resist; 2020 3rd Quarter; 3(3):586-602. PubMed ID: 33062960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.
    Desai B; Ma T; Zhu J; Chellaiah MA
    J Cell Biochem; 2009 Sep; 108(1):272-84. PubMed ID: 19582779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44-/- tumor cells, MEFs and macrophages.
    Schultz K; Grieger Lindner C; Li Y; Urbánek P; Ruschel A; Minnich K; Bruder D; Gereke M; Sechi A; Herrlich P
    PLoS One; 2018; 13(12):e0207358. PubMed ID: 30540779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CD44 intracellular domain production suppresses bovine articular chondrocyte de-differentiation induced by excessive mechanical stress loading.
    Sobue Y; Takahashi N; Ohashi Y; Suzuki M; Nishiume T; Kobayakawa T; Terabe K; Knudson W; Knudson C; Ishiguro N; Kojima T
    Sci Rep; 2019 Oct; 9(1):14901. PubMed ID: 31624271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
    Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
    Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
    Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element.
    Miletti-González KE; Murphy K; Kumaran MN; Ravindranath AK; Wernyj RP; Kaur S; Miles GD; Lim E; Chan R; Chekmareva M; Heller DS; Foran D; Chen W; Reiss M; Bandera EV; Scotto K; Rodríguez-Rodríguez L
    J Biol Chem; 2012 Jun; 287(23):18995-9007. PubMed ID: 22433859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.
    Zhang X; Wu H; Dobson JR; Browne G; Hong D; Akech J; Languino LR; Stein GS; Lian JB
    J Cell Biochem; 2015 Sep; 116(9):2098-108. PubMed ID: 25808168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
    Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
    Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2.
    Srinivasan D; Senbanjo L; Majumdar S; Franklin RB; Chellaiah MA
    J Cell Biochem; 2019 Feb; 120(2):2413-2428. PubMed ID: 30206982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.
    van der Deen M; Akech J; Wang T; FitzGerald TJ; Altieri DC; Languino LR; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    J Cell Biochem; 2010 Mar; 109(4):828-37. PubMed ID: 20082326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.
    Ge C; Zhao G; Li Y; Li H; Zhao X; Pannone G; Bufo P; Santoro A; Sanguedolce F; Tortorella S; Mattoni M; Papagerakis S; Keller ET; Franceschi RT
    Oncogene; 2016 Jan; 35(3):366-76. PubMed ID: 25867060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.
    Zheng QW; Zhou YL; You QJ; Shou F; Pang QF; Chen JL
    Cancer Gene Ther; 2016 Dec; 23(12):433-438. PubMed ID: 27834355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
    Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
    J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
    Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
    Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.